Zhenyu Xu insider trades: SOPHiA GENETICS (SOPH) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Zhenyu reports to the SEC
Open-market buys and sales
18 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 13, 2026 | SOPH | ↓ Sell10b5-1 | 4,000 | $7.18 | $29K | Direct | Oct 14, 2026 (1d) |
| Oct 5, 2026 | SOPH | ↓ Sell10b5-1 | 7,394 | $8.12 | $60K | Direct | Oct 7, 2026 (2d) |
| Sep 14, 2026 | SOPH | ↓ Sell10b5-1 | 4,000 | $7.88 | $32K | Direct | Sep 16, 2026 (2d) |
| Aug 27, 2026 | SOPH | ↓ Sell10b5-1 | 10,000 | $8.91 | $89K | Direct | Aug 31, 2026 (4d) |
| Aug 21, 2026 | SOPH | ↓ Sell10b5-1 | 20,000 | $8.17 | $163K | Direct | Aug 21, 2026 (0d) |
| Aug 13, 2026 | SOPH | ↓ Sell10b5-1 | 4,000 | $7.52 | $30K | Direct | Aug 14, 2026 (1d) |
| Aug 7, 2026 | SOPH | ↓ Sell10b5-1 | 20,000 | $7.25 | $145K | Direct | Aug 7, 2026 (0d) |
| Aug 4, 2026 | SOPH | ↓ Sell10b5-1 | 10,000 | $6.92 | $69K | Direct | Aug 5, 2026 (1d) |
| Jul 13, 2026 | SOPH | ↓ Sell10b5-1 | 4,000 | $5.70 | $23K | Direct | Jul 14, 2026 (1d) |
| Jul 6, 2026 | SOPH | ↓ Sell10b5-1 | 7,393 | $5.17 | $38K | Direct | Jul 7, 2026 (1d) |
| Jun 15, 2026 | SOPH | ↓ Sell10b5-1 | 4,000 | $5.01 | $20K | Direct | Jun 17, 2026 (2d) |
| May 19, 2026 | SOPH | ↓ Sell10b5-1 | 608 | $4.60 | $3K | Direct | May 20, 2026 (1d) |
| May 13, 2026 | SOPH | ↓ Sell10b5-1 | 4,000 | $4.54 | $18K | Direct | May 14, 2026 (1d) |
| Apr 14, 2026 | SOPH | ↓ Sell10b5-1 | 600 | $4.97 | $3K | Direct | Apr 16, 2026 (2d) |
| Apr 13, 2026 | SOPH | ↓ Sell10b5-1 | 8,120 | $4.73 | $38K | Direct | Apr 14, 2026 (1d) |
| Apr 9, 2026 | SOPH | ↓ Sell10b5-1 | 4,736 | $4.80 | $23K | Direct | Apr 10, 2026 (1d) |
| Apr 7, 2026 | SOPH | ↓ Sell10b5-1 | 5,100 | $4.86 | $25K | Direct | Apr 8, 2026 (1d) |
| Mar 19, 2026 | SOPH | ↓ Sell10b5-1 | 608 | $4.78 | $3K | Direct | Mar 20, 2026 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other SOPH insiders
Open-market trades in the last 12 months
About Zhenyu Xu's insider trades
Zhenyu Xu is Chief Scientific Officer at SOPHiA GENETICS (SOPH). Since Mar 19, 2026, Zhenyu has reported no open-market purchases and 18 sales worth $811K on SEC Form 4. In the last 12 months: 18 sales ($811K).
18 sales (100% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (2 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SOPH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.